dicersubstr
sirna
equip
cpg
oligodeoxyribonucleotid
overcom
major
hurdl
cellspecif
sirna
deliveri
cpgsirna
molecul
activ
intern
cell
without
need
transfect
reagent
lead
rna
interfer
vitro
vivo
elucid
molecular
mechan
cpgsirna
process
target
cell
show
shortli
uptak
earli
endosom
ee
cpg
sirna
part
conjug
uncoupl
presenc
dicer
endonucleas
dice
sirna
molecul
transloc
endosom
endoplasm
reticulum
interact
rna
interfer
machineri
previous
observ
even
though
involv
cpgsirna
uptak
indispens
induct
gene
silenc
explain
role
intracellular
process
cpgsirna
use
primari
macrophag
deriv
wildtyp
mice
macrophag
lack
show
extend
endosom
coloc
cpg
sirna
part
conjug
howev
ablat
interfer
interact
cpgsirna
dicer
shown
situ
proxim
ligat
assay
use
cpgsirna
label
phsensit
dye
final
identifi
lack
macrophag
result
signific
retent
sirna
endosom
thu
facilit
critic
step
follow
cpgsirna
uncoupl
cytoplasm
releas
dice
sirna
find
suggest
class
immunostimulatori
sirna
may
benefit
activ
sinc
discoveri
fire
mellow
sirna
proven
power
tool
modul
express
almost
gene
variou
speci
sever
studi
demonstr
feasibl
vivo
sirna
deliveri
lead
therapeut
effect
mice
also
nonhumanprim
recent
gene
silenc
system
sirna
administr
demonstr
human
howev
still
sever
hurdl
wide
therapeut
applic
technolog
cellspecif
sirna
deliveri
effici
releas
cytoplasm
sever
innov
attempt
solv
problem
use
modular
design
sirna
conjug
cellspecif
antibodi
rna
aptam
other
use
combin
sirna
lipid
reagent
cholesterol
enabl
sirna
uptak
without
need
molecul
encapsul
use
potenti
toxic
lipid
reagent
nevertheless
deliveri
method
result
endosom
rather
cytoplasm
sirna
uptak
due
rapid
progress
field
ration
design
sirna
reagent
hamper
gap
understand
intracellular
process
mani
deliveri
strategi
mechan
sirna
releas
cytoplasm
still
unclear
case
modifi
sirna
undergo
rapid
proton
endosom
suggest
releas
mechan
swell
burst
endosom
call
proton
spong
effect
process
explain
cytoplasm
releas
sirna
conjug
link
antibodi
rna
aptam
usual
limit
due
larg
size
time
sirna
releas
critic
load
earli
endosom
ee
undergo
seri
transform
event
call
matur
result
signific
decreas
endosom
ph
recruit
proteas
rnaas
convers
earli
late
endosom
may
take
littl
min
addit
min
requir
fuse
lysosom
lead
degrad
vesicl
content
addit
locat
variou
downstream
compon
sirna
process
machineri
well
defin
dicer
endonucleas
origin
found
cytoplasm
later
studi
indic
might
associ
endoplasm
reticulum
er
recent
report
found
endonucleas
major
compon
rnainduc
silenc
complex
risc
like
resid
multivesicular
bodi
mvb
intermedi
earli
late
endosom
find
agre
well
one
two
major
hypothes
risc
complex
assembl
identifi
surfac
ee
mvb
slight
variat
assumpt
risc
locat
pbodi
turn
associ
gwbodi
locat
cytoplasm
side
mvb
membran
contrast
other
shown
risc
coloc
larg
subunit
ribosom
anchor
rough
er
thu
block
translat
target
mrna
previous
develop
immunostimulatori
sirna
molecul
conjug
dicersubstr
sirna
cpg
oligodeoxyribonucleotid
odn
act
target
moieti
intracellular
tolllik
receptor
cpgsirna
success
use
target
variou
gene
normal
malign
cell
vitro
vivo
sirna
shown
gener
potent
system
antitumor
immun
prevent
tumor
metastasi
mous
model
recent
optim
cpgsirna
design
target
human
immun
cancer
cell
block
bclx
l
surviv
signal
inhibit
vivo
growth
sever
xenotranspl
blood
cancer
model
addit
conjug
retain
immunostimulatori
properti
activ
variou
popul
human
dc
b
cell
unexpect
find
recent
studi
express
activ
requir
target
gene
silenc
conjug
uptak
vitro
studi
use
cpgsirna
cell
fail
detect
rna
interfer
rnai
target
cell
delin
critic
initi
step
role
cpgsirna
process
believ
identifi
biomark
target
select
molecul
indispens
therapeut
effect
acceler
clinic
translat
cpgsirna
strategi
cancer
therapi
final
anticip
inform
support
acceler
ration
design
type
immunostimulatori
sirna
phosphorothio
odn
antisens
strand
sirna
link
use
unit
carbon
chain
linker
ch
glen
research
sterl
va
result
construct
hybrid
complementari
sens
strand
ss
sirna
creat
chimer
odnsirna
construct
deoxyribonucleotid
underlin
sequenc
singl
strand
construct
list
sirna
sequenc
specif
mous
gene
base
sirna
mous
sirna
ss
construct
fluoresc
label
use
fluorescein
fitc
lumiprob
hallandal
beach
fl
phrodo
life
technolog
carlsbad
ca
site
indic
text
fret
experi
gener
follow
construct
tripartit
design
use
complementari
stick
adapt
q
z
fitc
mous
sirna
ss
linkerstick
mous
sirna
confirm
modif
cpgsirna
conjug
variou
fluorochrom
alter
intern
target
cell
gene
silenc
effect
supplementari
fig
sequenc
firefli
luciferasespecif
sirna
r
use
cpg
luc
sirna
conjug
molecul
publish
elsewher
format
sirna
duplex
confirm
electrophoresi
urea
gel
mous
melanoma
fibroblast
raw
macrophag
cell
line
purchas
atcc
cultur
rpmi
medium
glutamax
life
technolog
fetal
bovin
serum
fb
cellgro
manassa
va
raw
cultur
dmem
glutamax
fb
bone
marrowderiv
macrophag
bmdm
differenti
bone
marrow
cell
wt
mice
describ
elsewher
differenti
statu
cpgsirna
uptak
effici
confirm
flow
cytometri
antibodi
bmdm
raw
cell
treat
use
nm
cpgsirna
min
cultur
medium
without
fb
respect
medium
replac
incub
continu
indic
time
cell
fix
paraformadehyd
min
permeabil
pb
contain
triton
mm
mgcl
mm
cacl
pbst
min
quench
mm
nh
clpbst
min
block
bsapbst
h
sampl
stain
antibodi
specif
dicer
santa
cruz
dalla
tx
xp
cell
signal
boston
calnexin
genscript
piscataway
nj
imgenex
san
diego
ca
fitc
life
technolog
sigma
st
loui
mo
detect
secondari
alexa
antibodi
life
technolog
slide
mount
dapicontain
mount
medium
vector
lab
burlingam
ca
confoc
imag
carri
use
capochromat
water
capochromat
water
planapochromat
oilimmers
object
invert
confoc
microscop
zeiss
thornwood
ny
use
lsm
softwar
imag
acquisit
lsm
imag
browser
postacquisit
analysi
zeiss
timelaps
confoc
microscopi
live
cell
cell
cultur
mm
glass
bottom
tissu
cultur
dish
mattek
ashland
wash
cell
twice
phenol
redfre
media
cell
treat
use
cpgsirna
min
imag
acquir
use
capochromat
water
immers
object
min
time
increment
z
stack
microscop
chamber
environment
control
co
use
experi
live
cell
quantif
purpos
zstack
collaps
postacquisit
signal
intens
select
region
interest
roi
determin
use
lsm
softwar
zeiss
experi
phrodolabel
cpgsirna
roi
encompass
singl
cell
roi
set
remain
constant
throughout
experi
revers
correl
intens
phrodo
succinimidyl
ester
emiss
ph
verifi
seri
mm
citric
buffer
ph
valu
supplementari
fig
experi
carri
quadrupl
intens
emiss
analyz
use
spectramax
fluoresc
plate
reader
molecular
devic
sunnyval
ca
use
nm
excit
nm
emiss
filter
fret
carri
live
raw
macrophag
tripartit
sirna
construct
label
fitc
within
carbon
linker
cpg
stick
adapt
end
sirna
design
allow
control
distanc
two
fluorophor
induc
fret
effect
cell
cultur
imag
acquisit
carri
describ
live
cell
time
seri
zstack
mode
intens
analyz
seri
zstack
project
use
lsm
macro
softwar
zeiss
nfret
xia
algorithm
stain
er
live
cell
use
green
er
tracker
life
technolog
concentr
stain
carri
hank
balanc
salt
solut
supplement
calcium
chlorid
magnesium
sulfat
glutamax
life
technolog
min
raw
cell
treat
cpgsirna
pellet
cryofix
leica
em
high
pressur
freezer
leica
buffalo
grove
il
specimen
freezesubstitut
anhydr
aceton
contain
glutaraldehyd
autom
freezer
substitut
system
leica
temperatur
progress
h
h
specimen
rins
aceton
time
infiltr
lowicryl
h
aceton
h
h
overnight
infiltr
specimen
polymer
lowicryl
h
h
uv
lamp
anoth
h
ultrathin
section
ca
nm
thick
cut
use
ultra
cut
uct
microtom
leica
pick
mesh
nickel
grid
post
embed
label
carri
use
rabbit
antifitc
antibodi
secondari
igg
antibodi
conjug
nm
colloid
gold
grid
stain
uranyl
acet
ethanol
min
follow
stain
reynold
lead
citrat
min
electron
microscopi
em
done
fei
tecnai
transmisison
electron
microscop
equip
ccd
camera
fei
hillsboro
cell
plate
onto
nunc
labtek
chamber
slide
thermo
fisher
scientif
marietta
oh
incub
overnight
prior
treatment
cpgsirna
duolink
situ
pla
carri
accord
manufactur
protocol
olink
uppsala
sweden
use
wt
bmdm
use
goat
antidic
rabbit
antifitc
primari
antibodi
pla
probe
antigoat
plu
antirabbit
minu
far
red
detect
reagent
olink
detect
coloc
event
intact
cell
slide
later
mount
scan
confoc
microscop
describ
zstack
imag
collaps
allow
quantif
total
pla
event
within
cell
sampl
duplic
analyz
least
scan
area
per
sampl
quantif
purpos
total
rna
isol
cdna
synthesi
carri
describ
previous
sampl
analyz
use
pair
primer
specif
cdna
qiagen
germantown
md
sequencespecif
amplif
detect
fluoresc
signal
sybr
green
qiagen
use
realtim
pcr
detector
biorad
hercul
ca
mous
care
experiment
procedur
perform
pathogenfre
condit
accord
approv
protocol
iacuc
citi
hope
subcutan
tumor
challeng
inject
tumor
cell
week
old
wt
mice
kindli
provid
dr
diamond
citi
hope
tumor
reach
averag
size
ca
mm
mice
inject
peritumor
nmole
mgkg
cpgsirna
tumor
growth
monitor
everi
day
use
electron
calip
analysi
gene
silenc
mice
euthan
day
treatment
tumor
drain
lymph
node
collect
cell
magnet
enrich
use
easysep
kit
stem
cell
technolog
vancouv
canada
describ
previous
singl
cell
suspens
cultur
lymph
node
cell
prepar
mechan
tissu
disrupt
collagenas
ddnase
treatment
describ
stain
bd
bioscienc
san
jose
ca
analyz
conjug
intern
raw
cell
pretreat
use
dextran
sulfat
chondroitin
sulfat
sigma
h
prior
treatment
nm
cpgsirna
h
assess
uptak
cell
place
ice
min
stimul
stimul
nm
sirna
min
immedi
analyz
flow
cytometri
fluoresc
data
collect
bd
accuri
cytomet
bd
bioscienc
analyz
use
flowjo
softwar
tree
star
ashland
unpair
twotail
ttest
use
calcul
twotail
p
valu
estim
statist
signific
differ
two
treatment
group
whole
studi
statist
signific
p
valu
indic
figur
andor
legend
label
follow
p
p
p
data
analyz
use
prism
softwar
graphpad
la
jolla
ca
previou
studi
demonstr
immunostimulatori
sirna
conjug
potent
antitumor
therapeut
mous
human
system
even
though
particip
cpgsirna
uptak
critic
silenc
variou
target
gene
vitro
mous
human
cell
altogeth
result
prompt
us
elucid
role
facilit
cpgsirnamedi
gene
silenc
effect
first
assess
process
cpgsirna
intern
target
immun
cell
previous
demonstr
cpgsirna
rapidli
enter
target
cell
endocytosi
cpg
fitc
sirna
clearli
detect
endosom
within
less
min
incub
shown
transmiss
electron
microscopi
fig
agreement
previou
studi
cpgsirna
activ
intern
target
immun
cell
normal
physiolog
condit
process
abrog
supplementari
fig
intern
cpg
odn
reportedli
mediat
surfac
receptor
scaveng
famili
due
function
redund
scaveng
receptor
sr
decid
assess
effect
dextran
sulfat
gener
competit
sr
inhibitor
cpgsirna
uptak
describ
shown
fig
preincub
raw
cell
dextran
sulfat
block
intern
cpgsirna
measur
use
flow
cytometri
contrast
control
chondroitin
sulfat
bind
sr
fail
affect
conjug
intern
design
cpgsirna
util
dicersubstr
sirna
sequenc
enabl
cleavag
molecul
releas
sirna
receptorbound
cpg
fragment
conjug
assess
time
effici
cpgsirna
cleavag
develop
situ
confoc
imag
approach
base
fluoresc
reson
energi
transfer
fret
part
conjug
cpgsirna
molecul
equip
fitc
label
donor
linker
region
label
acceptor
ad
via
anoth
linker
end
sirna
antisens
strand
flexibl
linker
region
permit
close
proxim
fluorochrom
requir
energi
transfer
excit
donor
acceptor
result
emiss
spectrum
max
nm
donoracceptor
pair
would
separ
conjug
cleavag
dicer
endonucleas
part
cpg
fitc
linkerstick
sirna
short
termin
fragment
sirna
verifi
chang
fret
intens
result
process
sirna
part
conjug
compar
emiss
spectra
dual
sirna
without
nucleas
resist
modifi
sirna
shown
fig
raw
cell
fret
effect
induc
unmodifi
conjug
transient
decreas
half
within
h
contrast
fret
signal
induc
cpgsirna
remain
elev
even
slightli
increas
h
result
suggest
cpgsirna
process
occur
earli
intern
requir
cleavag
sirna
part
molecul
next
investig
whether
kinet
cpgsirna
interact
dicer
coincid
rapid
uncoupl
conjug
first
confirm
use
confoc
microscopi
alreadi
h
cpgsirna
uptak
conjug
coloc
dicer
endosom
vesicl
fig
fact
dicer
found
similar
vesicular
local
raw
cell
even
treatment
supplementari
fig
thu
cpgsirna
uncoupl
occur
right
intern
contain
endosom
direct
proof
interact
dicer
substrat
cpgsirna
use
situ
proxim
ligat
assay
pla
enabl
visual
quantif
interact
two
molecul
intact
fix
cell
briefli
molecul
examin
identifi
pair
unconjug
primari
antibodi
igg
secondari
antibodi
equip
dna
primer
form
circular
templat
close
proxim
circular
dna
becom
templat
roll
circl
dna
polymeras
amplifi
dna
repeat
repeat
recogn
complimentari
oligonucleotid
label
fluorophor
fluoresc
signal
detect
use
confoc
microscopi
use
antibodi
specif
dicer
fluorescein
cpg
fitc
sirna
found
molecul
colocol
mous
macrophag
earli
h
treatment
reach
maximum
h
decreas
thereaft
fig
result
demonstr
dicer
interact
cpgsirna
coincid
sirna
uncoupl
observ
fret
assay
thu
underscor
role
dicer
initi
cpgsirna
process
induc
gene
silenc
sirna
uncoupl
cpgsirna
conjug
must
leav
endosom
bind
protein
critic
compon
risc
complex
initi
confoc
microscopi
studi
mous
macrophag
show
detect
subset
ee
basal
condit
supplementari
fig
also
associ
er
cpgsirna
treatment
fig
follow
traffick
fluoresc
label
sirna
molecul
raw
cell
use
duallabel
cpg
fitc
sirna
allow
us
visual
part
conjug
cleavag
also
includ
cpgsirna
neg
control
similar
shown
fig
confoc
microscopi
analysi
show
initi
coloc
cpg
fitc
sirna
part
unmodifi
conjug
clearli
separ
h
fig
top
row
sirna
molecul
found
vesicl
within
endoplasm
reticulum
confirm
stain
er
maker
calnexin
fig
contrast
cpg
fitc
contain
distinct
vesicular
compart
fig
use
stain
rab
late
endosom
marker
confirm
cpg
fragment
fact
remain
matur
endosom
like
bound
supplementari
fig
confirm
sirna
effici
escap
earli
rather
matur
endosom
use
chloroquin
commonli
use
inhibitor
endosom
acidif
caus
burst
matur
endosom
compar
level
silenc
induc
raw
cell
sirna
control
nontarget
cpgluc
sirna
presenc
absenc
chloroquin
shown
fig
chloroquin
affect
gene
silenc
confirm
sirna
molecul
effici
uncoupl
releas
without
signific
endosom
retent
final
verifi
whether
effect
oligonucleotid
experi
result
abil
act
potent
antagonist
control
experi
detect
differ
sirna
transport
er
presenc
absenc
cpgsirna
supplementari
fig
previous
shown
activ
requir
target
gene
silenc
conjug
uptak
assess
whether
play
role
endosom
releas
dice
sirna
use
primari
bone
marrowderiv
macrophag
bmdm
wt
mice
first
address
question
whether
express
requir
cpgsirna
interact
dicer
pla
assay
macrophag
treat
cpg
fitc
sirna
indic
dicer
endonucleas
coloc
cpgsirna
wt
cell
independ
tlr
statu
supplementari
fig
howev
transient
interact
significantli
extend
cell
suggest
impair
cpgsirna
process
endosom
releas
explain
observ
incub
primari
wt
macrophag
duallabel
cpg
fitc
sirna
assess
intracellular
conjug
process
confoc
microscopi
releas
dice
sirna
ee
delay
cell
coloc
fluoresc
signal
still
detect
h
treatment
contrast
wt
cell
supplementari
fig
direct
proof
sirna
endosom
releas
gener
sirna
label
phsensit
fluoresc
dye
phrodo
fluoresc
intens
emiss
phrodo
invers
correl
ph
environ
thu
permit
detect
chang
ph
due
transit
ee
ph
either
cytoplasm
ph
late
endosom
ph
supplementari
fig
use
timelaps
imag
record
digit
quantifi
chang
phrodo
intens
primari
wt
macrophag
treat
cpgsirna
shown
fig
intens
fluoresc
signal
phrodo
wt
cell
decreas
rapidli
h
incub
bare
detect
h
contrast
signal
intens
cell
drop
initi
remain
rel
unchang
h
verifi
observ
chang
phrodo
intens
fact
result
conjug
cleavag
cytoplasm
releas
sirna
repeat
experi
use
cpgsirna
similar
fig
supplementari
fig
confirm
earlier
observ
fig
small
fraction
unprocess
conjug
releas
endosom
wt
cell
cell
releas
intact
conjug
neglig
result
increas
phrodo
signal
progress
endosom
acidif
supplementari
fig
next
verifi
whether
activ
also
involv
transloc
dice
sirna
er
incub
wt
bmdm
presenc
fluoresc
label
cpgsirna
h
h
analyz
coloc
sirna
er
use
confoc
microscopi
live
cell
shown
fig
sirna
signal
detect
within
er
wt
cell
start
h
increas
h
incub
contrast
macrophag
show
weak
coloc
sirna
er
even
h
therebi
indic
role
process
summari
find
found
graphic
abstract
supplementari
fig
previous
develop
cpgsirna
strategi
allow
target
gene
silenc
variou
cell
vitro
vivo
mous
human
target
cell
essenti
induct
rnai
intriguingli
found
defici
affect
cpgsirna
uptak
current
studi
use
variou
imag
approach
confoc
transmiss
electron
microscopi
elucid
role
intracellular
receptor
permit
cpgsirna
effect
studi
establish
mous
macrophag
well
primari
immun
cell
demonstr
shortli
dicermedi
cleavag
conjug
facilit
releas
uncoupl
sirna
ee
matur
fulli
function
locat
ee
thu
directli
respons
ligand
intern
result
identifi
cpgsirna
undergo
endocytosi
dextran
sulfatesensit
receptor
scaveng
famili
observ
agre
well
previou
report
suggest
role
sever
scaveng
receptor
cpg
odn
intern
includ
other
due
function
redund
addit
bind
cofactor
also
affect
oligonucleotid
deliveri
especi
vivo
shown
granulinbound
cpg
odn
drastic
enhanc
deliveri
endosom
thu
cpgsirna
intern
also
srposit
target
cell
howev
sr
known
express
mostli
immun
cell
abil
intern
macromolecul
dendrit
cell
macrophag
b
cell
also
express
thu
cpgsirna
uptak
mous
human
target
cell
usual
correl
constitut
induc
express
differenti
monocyt
scenario
cpg
odn
quickli
intern
ee
bind
present
locat
quickli
min
treatment
found
similar
rapid
kinet
intern
also
case
cpgsirna
conjug
interestingli
fret
studi
indic
endonucleasedepend
uncoupl
sirna
cpg
part
occur
earli
uptak
conjug
still
ee
extend
sirna
molecul
known
target
dicer
trim
molecul
sirna
previous
shown
vitro
dicer
cleav
cpgsirna
similar
manner
releas
sirna
current
studi
verifi
result
live
fix
cell
use
fret
confoc
imag
demonstr
first
time
dicer
coloc
endosom
compart
transient
interact
target
oligonucleotid
ee
earli
min
conjug
uptak
remain
determin
whether
dicer
oper
insid
endosom
rather
endosom
membran
compon
rnai
machineri
locat
rapid
process
cpgsirna
critic
effici
induct
rnai
experi
chloroquin
inhibitor
endosom
matur
confirm
sirna
releas
effect
like
occur
convers
ee
mvb
late
endosom
uncoupl
sirna
molecul
seem
escap
ee
undergo
acidif
fuse
lysosom
start
degrad
content
follow
endosom
escap
sirna
molecul
must
enter
risc
order
initi
rnai
suggest
recent
studi
major
risc
compon
present
cytoplasm
side
membran
endosom
er
result
show
constitut
present
ee
well
partli
associ
er
cell
treat
cpgsirna
conjug
also
found
uncoupl
cpgsirna
conjug
dice
sirna
transloc
er
accord
multipl
refer
sirna
process
dicer
immedi
pass
trbp
protein
part
risc
load
complex
bind
dicer
bind
effect
protect
guid
strand
sirna
hazard
nucleas
throughout
rnai
process
anticip
presenc
ee
er
facilit
transfer
sirna
one
locat
anoth
suggest
result
indic
reloc
newli
form
endosom
cellular
membran
toward
perinuclear
cistern
er
transport
mechan
implement
motor
protein
dynein
kinesin
would
elimin
need
releas
nake
sirna
cytoplasm
viscos
concentr
nucleas
high
fusion
newli
form
endosom
er
previous
shown
macrophag
known
induc
format
similar
tubular
phagosom
process
relat
antigen
crosspresent
allow
deliveri
phagosom
antigen
mhc
class
complex
variou
immun
cell
dc
macrophag
b
cell
antigen
crosspresent
phagosom
fuse
er
acquir
number
erspecif
protein
critic
transmembran
transport
variou
molecul
activ
known
stimul
phagocytosi
crosspresent
antigen
cytosol
specif
regul
microtubuleassist
transport
ee
toward
er
earli
releas
endosom
content
acidif
result
suggest
similar
mechan
may
employ
releas
sirna
dice
cpgsirna
conjug
seem
requir
recruit
dicer
alreadi
present
ee
howev
experi
macrophag
provid
evid
facilit
endosom
releas
uncoupl
sirna
studi
establish
whether
canon
downstream
signal
regul
releas
sirna
uncoupl
cpgsirna
conjug
addit
involv
endosom
tlr
conjug
process
sirna
releas
exclud
address
experi
specif
tlrdefici
cell
model
cpgsirna
strategi
show
promis
cancer
immunotherapeut
target
immunosuppress
regul
also
demonstr
approach
suitabl
direct
elimin
human
cancer
cell
certain
blood
cancer
intriguingli
studi
identifi
differ
effici
target
gene
silenc
human
cell
use
sirna
conjug
aand
btype
cpg
odn
kortylewski
unpublish
data
sinc
variou
type
cpg
odn
differ
time
type
downstream
signal
like
event
critic
determin
cpgsirna
efficaci
find
impli
trigger
might
also
enhanc
endosom
releas
sirna
deliv
cpg
odn
strategi
includ
rna
aptam
monoclon
antibodi
believ
understand
requir
effect
induct
rnai
target
cell
facilit
optim
cpgsirna
potenti
also
sirna
deliveri
approach
human
cancer
therapi
refer
web
version
pubm
central
supplementari
materi
cpgsirna
conjug
uncoupl
presenc
dicer
endonucleas
shortli
intern
raw
cell
separ
cpg
sirna
part
cpg
fitc
sirna
conjug
measur
decreas
fret
effect
use
timelaps
confoc
microscopi
nucleaseresist
conjug
complet
strand
sirna
use
neg
control
shown
repres
result
one
three
independ
experi
scale
bar
b
quantif
averag
fret
intens
three
independ
experi
use
unmodifi
conjug
shown
mean
sem
c
cpgsirna
coloc
dicer
within
h
uptak
assess
confoc
microscopi
fix
raw
macrophag
e
dicer
transient
interact
cpgsirna
shortli
endocytosi
conjug
cell
incub
cpg
fitc
sirna
indic
time
fix
permeabil
interact
cpg
fitc
sirna
dicer
detect
situ
pla
use
fitcand
dicerspecif
antibodi
shown
confoc
microscopi
imag
z
stack
project
scale
bar
e
averag
count
pla
event
per
cell
indic
time
mean
sem
intracellular
local
part
cpgsirna
endosom
process
unmodifi
top
row
bottom
row
cpg
fitc
sirna
ad
cultur
raw
cell
h
cell
fix
stain
anticalnexin
antibodi
er
marker
plu
dapi
nuclear
stain
shown
white
analyz
confoc
microscopi
scale
bar
c
disrupt
late
endosom
chloroquin
affect
target
gene
silenc
sirna
gene
silenc
measur
use
qpcr
cell
treat
sirna
cpglucsirna
neg
control
without
chloroquin
inhibitor
endosom
matur
indic
shown
repres
result
one
two
independ
experi
mean
sem
requir
effici
releas
dice
sirna
ee
repres
imag
timelaps
confoc
microscopi
wt
primari
bonemarrow
deriv
macrophag
treat
use
cpgsirna
label
phsensit
fluoresc
dye
phrodo
h
shown
singl
confoc
z
layer
scale
bar
rel
averag
intens
phrodo
emiss
function
time
b
result
averag
individu
cell
mean
sem
shown
result
one
two
wt
three
independ
experi
c
requir
effici
transloc
dice
sirna
endosom
er
confoc
microscopi
live
wt
primari
bmdm
treat
use
cpgsirna
indic
time
intravit
stain
use
green
er
tracker
singl
z
layer
scale
bar
